Our prescription options, such as Wegovy, Oral Wegovy, Zepbound, and Foundayo, are specifically approved for weight management
Although its findings are limited because of its small size, the clear differences between the groups provide early data to support larger trials
Our findings uncover an extra-organellar buffering mechanism whereby partial v-ATPase inhibition mitigates mitochondrial dysfunction by altering pH homeostasis and driving metabolic rewiring as a protective response that promotes cell fitness
Hwa V, Haeusler G, Pratt KL, Little BM, Frisch H, Koller D, Rosenfeld RG: Total absence of functional acid labile subunit, resulting in severe insulin-like growth factor deficiency and moderate growth failure